FITC標(biāo)記的乙型肝炎e抗原抗體產(chǎn)品應(yīng)用

FITC標(biāo)記的乙型肝炎e抗原抗體產(chǎn)品應(yīng)用

中文名稱(chēng) FITC標(biāo)記的乙型肝炎e抗原抗體 
規(guī)格價(jià)格 100ul
抗體來(lái)源 Rabbit 
克隆類(lèi)型 Polyclonal 
交叉反應(yīng)  
產(chǎn)品應(yīng)用 
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user. 
分 子 量 12kDa 
性    狀 Lyophilized or Liquid 
濃    度 1mg/ml 
免 疫 原 KLH conjugated synthetic peptide derived from human HBeAg 
亞    型 IgG 
純化方法 affinity purified by Protein A 
儲(chǔ) 存 液 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. 
保存條件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. 

產(chǎn)品介紹 background:
Hepatitis B e-antigen (HBeAg) is a viral protein associated with HBV infections. Unlike the surface antigen, the e-antigen is found in the blood only when there are viruses also present. When the virus goes into “hiding,” the e-antigen will no longer be present in the blood. HBeAg is often used as a marker of ability to spread the virus to other people (infectivity). Measurement of e-antigen may also be used to monitor the effectiveness of HBV treatment; successful treatment will usually eliminate HBeAg from the blood and lead to development of antibodies against e-antigen (anti-HBe). There are some types (strains) of HBV that do not make e-antigen; these are especially common in the Middle East and Asia. In areas where these strains of HBV are common, testing for HBeAg is not very useful.

Function:
May regulate immune response to the intracellular capsid in acting as a T-cell tolerogen, by having an immunoregulatory effect which prevents destruction of infected cells by cytotoxic